Rates of VTE, Major Bleeding High in Primary CNS Lymphoma
FRIDAY, Nov. 20, 2020 -- For patients with primary central nervous system lymphoma (PCNSL), the incidence of venous thromboembolism (VTE) and major bleeding is high, according to a study published in the November issue of Leukemia & Lymphoma.
Anjlee Mahajan, M.D., from the University of California Davis School of Medicine in Sacramento, and colleagues determined the cumulative incidence of VTE and major bleeding using California hospitalization data for 992 PCNSL patients using the California Cancer Registry (2005 to 2014).
The researchers found that the 12-month cumulative incidence of VTE and major bleeding was 13.6 and 12.4 percent, respectively. An increased risk for VTE was seen in association with chemotherapy and radiation therapy (hazard ratios, 2.41 and 1.56, respectively). The risk for major bleeding was increased in association with pulmonary embolism and proximal deep vein thrombosis, likely due to anticoagulation. Increased mortality was seen in association with pulmonary embolism and major bleeding (hazard ratios, 1.61 and 2.36, respectively).
"Development of a clinical prediction model for both VTE and major bleeding in patients with PCNSL may also help guide decisions on thromboprophylaxis which could mitigate the need for therapeutic anticoagulation in this high risk population," the authors write.
© 2020 HealthDay. All rights reserved.
Posted: November 2020
Read this next
TUESDAY, Oct. 13, 2020 -- High levels of physical activity may lower the risk for developing lymphoma, according to a review/meta-analysis published online Oct. 6 in BMC...
WEDNESDAY, Oct. 7, 2020 -- The overall prevalence of venous thromboembolism (VTE) in patients with COVID-19 is estimated to be 14.1 percent, with a higher prevalence for patients...
WEDNESDAY, Sept. 23, 2020 -- Children with current glucocorticoid exposure have increased risks for diabetes mellitus, hypertension, and venous thromboembolism (VTE), according to...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.